Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia

Bone Marrow Transplantation

Volumn 25, Issue 8, 2000, Pages 843-851

  Zetterquist, H ^a   Mattsson, J ^a   Uzunel, M ^a   Nasman Bjork I ^a   Svenberg, P ^a   Tammik, L ^a   Bayat, G ^a   Winiarski, J ^a   Ringden O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute lymphoblastic leukemia; Allogeneic hematopoietic cell transplantation; Chimerism; Minimal residual disease; Relapse

Indexed keywords

CD19 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CHILD; CHIMERA; CLINICAL ARTICLE; FEMALE; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN GENE; MALE; MINIMAL RESIDUAL DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; SCHOOL CHILD; T LYMPHOCYTE RECEPTOR GENE;

EID: 0034034527     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702337     Document Type: Article

References (53)

1. Thomas ED, Sanders JE, Flournoy N et al. Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 1979; 54: 468-476.
2. Barrett AJ, Horowitz MM, Pollock BH et al. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission. New Engl J Med 1994; 331: 1253-1258.
3. Saarinen UM, Mellander L, Nysom K et al. Allogeneic bone marrow transplantation in first remission for children with very high-risk acute lymphoblastic leukemia: a retrospective case-control study in the Nordic countries. Nordic Society for Pediatric Hematology and Oncology (NOPHO). Bone Marrow Transplant 1996; 17: 357-363.
4. Burnett AK, Eden OB. The treatment of acute leukaemia. Lancet 1997; 349: 270-275.
5. Nizet Y, Van Daele S, Lewalle P et al. Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction. Blood 1993; 82: 1618-1625.
6. Roberts WM, Estrov Z, Ouspenskaia MV et al. Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia. New Engl J Med 1997; 336: 317-323.
7. Alard P, Matriano JA, Socarras S et al. Detection of donor-derived cells by polymerase chain reaction in neonatally tolerant mice. Microchimerism fails to predict tolerance. Transplantation 1995; 60: 1125-1130.
8. Radich JP, Gehly G, Gooley T et al. Polymerase chain reaction detection of the BCR-ABL fusion transcript after allogeneic marrow transplantation for chronic myeloid leukemia: results and implications in 346 patients. Blood 1995; 85: 2632-2638.
9. Norris MD, Kwan E, Haber M, Marshall GM. Detection of evolving immunoglobulin heavy-chain gene rearrangements in acute lymphoblastic leukemia: a PCR-based assay employing overlapping DJH primers. Leukemia 1995; 9: 1779-1782.
10. Burlingham WJ. Chimerism after organ transplantation: is there any clinical significance? Clin Transplant 1996; 10: 110-117.
11. Mackinnon S, Barnett L, Heller G. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 1996; 17: 643-647.
12. Yokota S, Hansen-Hagge TE, Bartram CR. T-cell receptor delta gene recombination in common acute lymphoblastic leukemia: preferential usage of V delta 2 and frequent involvement of the J alpha cluster. Blood 1991; 77: 141-148.
13. Beishuizen A, Verhoeven MA, van Wering ER et al. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis. Blood 1994; 83: 2238-2247.
14. Hagelberg E, Gray IC, Jeffreys AJ. Identification of the skeletal remains of a murder victim by DNA analysis. Nature 1991; 352: 427-429.
15. Ugozzoli L, Yam P, Petz LD et al. Amplification by the polymerase chain reaction of hypervariable regions of the human genome for evaluation of chimerism after bone marrow transplantation. Blood 1991: 77: 1607-1615.
16. Mackinnon S, Barnett L, Bourhis JH et al. Myeloid and lymphoid chimerism after T-cell-depleted bone marrow transplantation: evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood 1992; 80: 3235-3241.
17. Steward CG, Goulden NJ, Katz F et al. A polymerase chain reaction study of the stability of lg heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia. Blood 1994; 83: 1355-1362.
18. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
19. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
20. Oakhill A, Pamphilon DH, Potter MN et al. Unrelated donor bone marrow transplantation for children with relapsed acute lymphoblastic leukaemia in second complete remission. Br J Haematol 1996; 94: 574-578.
21. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
22. Ringden O, Pihlstedt P, Markling L et al. Prevention of graftversus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221-226.
23. Budowle B, Chakraborty R, Giusti AM et al. Analysis of the VNTR locus DIS80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 1991: 48: 137-144.
24. Horn GT, Richards B, Klinger KW. Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acids Res 1989; 17: 2140.
25. Eubanks JH, Selleri L, Hart R et al. Isolation, localization, and physical mapping of a highly polymorphic locus on human chromosome 11q13. Genomics 1991; 11: 720-729.
26. Decorte R, Cuppens H, Marynen P, Cassiman JJ. Rapid detection of hypervariable regions by the polymerase chain reaction technique. DNA Cell Biol 1990; 9: 461-469.
27. Buchmayer H, Rumpold H, Mannhalter C. Identification of a variable number tandem repeat region in the human T cell receptor alpha-delta (TCRAD) locus. Hum Genet 1996; 98: 333-335.
28. Jeffreys AJ, Wilson V, Neumann R, Keyte J. Amplification of human minisatellites by the polymerase chain reaction: towards DNA fingerprinting of single cells. Nucleic Acids Res 1988; 16: 10953-10971.
29. Yamada M, Hudson S, Tournay O et al. Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc Natl Acad Sci USA 1989; 86: 5123-5127.
30. Steward CG, Goulden NJ, Potter MN, Oakhill A. The use of the polymerase chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia. Eur J Cancer 1993; 29A: 1192-1198.
31. van Dongen JJ, Breit TM, Adriaansen HJ et al. Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction. Leukemia 1992; 1: 47-59.
32. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
33. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. John Wiley and Sons: New York, 1980.
34. Ramirez M, Diaz MA, Garcia-Sanchez F et al. Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 1996; 18: 1161-1165.
35. Bader P, Beck J, Frey A et al. Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998; 21: 487-495.
36. Estrov Z, Ouspenskaia MV, Felix EA et al. Persistence of self-renewing leukemia cell progenitors during remission in children with B-precursor acute lymphoblastic leukemia. Leukemia 1994; 8: 46-52.
37. Roux E, Abdi K, Speiser D et al. Characterization of mixed chimerism in patients with chronic myeloid leukemia transplanted with T-cell-depleted bone marrow: involvement of different hematologic lineages before and after relapse. Blood 1993; 81: 243-248.
38. van Leeuwen JE, van Tol MJ, Joosten AM et al. Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 1993; 82: 1921-1928.
39. Moos M, Schulz R, Cremer F et al. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies. Stem Cells 1995; 3: 42-51.
40. Gardiner N, Lawler M, O'Riordan JM et al. Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia. Bone Marrow Transplant 1998; 21: 711-719.
41. Li HH, Gyllensten UB, Cui XF et al. Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature 1988; 335: 414-417.
42. Simmons PJ, Przepiorka D, Thomas ED, Torok-Storb B. Host origin of marrow stromal cells following allogeneic bone marrow transplantation. Nature 1987; 328: 429-432.
43. McCann SR, Lawler M. Mixed chimaerism: detection and significance following BMT. Bone Marrow Transplant 1993; 11: 91-94.
44. Roux E, Helg C, Dumont-Girard F et al. Analysis of T-cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T-cell depleted and unmanipulated grafts. Blood 1996; 87: 3984-3992.
45. Lawler M, Humphries P, McCann SR. Evaluation of mixed chimerism by in vitro amplification of dinucleotide repeat sequences using the polymerase chain reaction. Blood 1991; 77: 2504-2514.
46. Molloy K, Goulden N, Lawler M et al. Patterns of hematopoietic chimerism following bone marrow transplantation for childhood acute lymphoblastic leukemia from volunteer unrelated donors. Blood 1996; 87: 3027-3031.
47. Green E, McConville CM, Powell JE et al. Clonal diversity of Ig and T-cell-receptor gene rearrangements identities a subset of childhood B-precursor acute lymphoblastic leukemia with increased risk of relapse. Blood 1998; 92: 952-958.
48. Knechtli CJ, Goulden NJ, Hancock JP et al. Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia. Blood 1998; 92: 4072-4079.
49. Langlands K, Goulden NJ, Steward CG et al. False-positive residual disease assessment after bone marrow transplant in acute lymphoblastic leukemia. Blood 1994; 84: 1352-1353.
50. Campana D, Pui CH. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance. Blood 1995; 85: 1416-1434.
51. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462-2465.
52. Bader P, Beck J, Schlegel PG et al. Additional immunotherapy on the basis of increasing mixed hematopoietic chimerism after allogeneic BMT in children with acute leukemia: is there an option to prevent relapse? Bone Marrow Transplant 1997; 20: 79-81.
53. Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood 1998; 91: 756-763.